tradingkey.logo

Nasus Pharma Ltd

NSRX
查看詳細走勢圖
5.440USD
-0.280-4.83%
收盤 02/06, 16:00美東報價延遲15分鐘
49.28M總市值
虧損本益比TTM

Nasus Pharma Ltd

5.440
-0.280-4.83%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-4.83%

5天

-5.23%

1月

-19.76%

6月

0.00%

今年開始到現在

-40.55%

1年

0.00%

查看詳細走勢圖

TradingKey 股票評分

由於缺少必要的數據,暫時無法對該公司進行評分

Nasus Pharma Ltd新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Nasus Pharma Ltd簡介

Nasus Pharma Ltd is an Israel-based pharmaceutical company. The Company conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The Company's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.
公司代碼NSRX
公司Nasus Pharma Ltd
CEOTeleman (Dan)
網址https://www.nasuspharma.com
KeyAI